Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Is HRT justified for symptom management in women at higher risk of developing breast cancer?

Climacteric : the journal of the International Menopause Society - 1 Dec 2006

Rippy L, Marsden J

Abstract excerpt

Hormone replacement therapy (HRT) is the most efficacious intervention for the treatment of estrogen-deficiency symptoms. Prescriptions for HRT have fallen over the last 3 years due to anxiety provoked about breast cancer risk and recurrence that has been generated by recent clinical trials. In w...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Breast Neoplasms
Share to Estrogen Replacement Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Neoplasm Recurrence, Local

Share to Patient Education as Topic

Share to Risk Assessment

Share to Risk Factors

Source

Identifiers

PMID: 17085372
DOI: 10.1080/13697130601022367

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Prepared record publication-17085372-2026-09-05.1. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Is HRT justified for symptom management in women at higher risk of developing breast cancer?PMID 17085372Read ↗

Hormonal management after risk-reducing surgery in BRCA-mutated triple-negative breast cancer survivors.Semantic proximity Read ↗

Breast Cancer Risk Reduction Clinical Practice Guidelines in Oncology.Semantic proximity Read ↗

The menopause, hormone replacement therapy and breast cancer.Semantic proximity Read ↗

Is Hormone Replacement Therapy Safe in Women With a BRCA Mutation?: A Systematic Review of the Contemporary Literature.Semantic proximity Read ↗

Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey.Semantic proximity Read ↗

Breast cancer and replacement therapy: which women are at risk?Semantic proximity Read ↗

Breast cancer risk and hormone replacement therapy among BRCA carriers after risk-reducing salpingo-oophorectomy.Semantic proximity Read ↗

Breast cancer prevention: present and future.Semantic proximity Read ↗

Exogenous reproductive hormone use in breast cancer survivors and previvors.Semantic proximity Read ↗

Hormone Therapy in Breast Cancer Survivors and Those at High Risk for Breast Cancer.Semantic proximity Read ↗

Preventing breast cancer in high-risk women, 2008.Semantic proximity Read ↗

Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.